This is in line with emerging research that has linked AD with common T2DM phenomena, such as insulin resistance, dysfunctional insulin signaling, neuroinflammation, advanced glycosylation end products (AGEs), and metabolic dysfunction [22], earning it the name “type 3 diabetes” [23]. The gene discussed is INS; the disease is Insulin resistance.